Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-48

First 48 Last

Share
Profile

Follow
zecs

924 Posts.

438

21/02/25

11:01

Post #: 77961968
Share

Originally posted by bcr: ↑

You are a fool to try to portray Indonesia as the "end game".

Let's say, your figures are correct, and there ends up being 50,000 patients treated with R327 across Indonesia @$50 a pop. 93% of treatments are successful within 14 days.

Now, what would the FDA, the EMA, and the TGA would make of that?

I think they might sit up and take notice.
Imagine how the US military would react.

If they decide to investigate further, they may agree that RCE327 is safe, effective, and cheap! What's more, treatment is easy and you don't have to wait for lab results. You could treat someone in a clinic in outback Irian Jaya, without having to fly them, or lab samples, to a major city.

It would be utter madness to dismiss successful Indonesian trials as irrelevant.

Expand

The FDA, the TGA, the EMA will not give a flying rats arse about results in an Indonesia trial, I can assure you.

If Indo was some sort of magical short cut, every biotech in the world would be doing it.

If quick revenue is not the purpose, then there is literally no reason to bother with this trial.

If the goo is so effective, why not go straight to a trial under an IND in the USA (or somewhere sensible?

There is only one reason I can think of and it involves gravy being near a train.

RCE Price at posting: 42.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

MQR

'We're extremely encouraged': Marquee expands footprint at Mt Clement

LTR

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

First 48 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 37.5¢		Change 0.005(1.35%)		Mkt cap ! $108.4M

Open	High	Low	Value	Volume
38.0¢	38.5¢	37.0¢	$10.23K	27.28K

Buyers (Bids)

No.	Vol.	Price($)
1	3019	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	9138	1

View Market Depth

No.	Vol.	Price($)
1	3019	0.370
2	50531	0.365
4	84700	0.360
2	85000	0.355
4	88019	0.350

Price($)	Vol.	No.
0.375	9138	1
0.380	14994	2
0.390	51543	3
0.400	23104	2
0.410	25471	1

Last trade - 16.10pm 07/08/2025 (20 minute delay)

RCE (ASX) Chart

Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-48

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-48

Top Stories

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News